ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 655748 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 655748; 2) Community: the network communities that were significantly associated with the response to NSC 655748; 3) Molecule: the relationships between components within communities and NSC 655748; 4) MDR: the compounds that were significantly associated with the NSC 655748.

NSC Compound Enrichment Correlation
NSC 672210 Null 0.0480633950058475 0.28283654
NSC 684409 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone 0.0480633950058475 0.26022096
NSC 685964 Null 0.0480633950058475 0.116302
NSC 697535 Null 0.0480633950058475 0.080060833
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.0480633950058475 0.025356574
NSC 715407 Null 0.0480633950058475 0.24045895
NSC 716002 Null 0.0480633950058475 0.14719946
NSC 726217 Combretastatin A4-analogue 0.0480633950058475 0.25481086
NSC 726578 Null 0.0480633950058475 0.29076541
NSC 727620 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride 0.0480633950058475 0.10654923
Total:80  Current:78    [First] [Prev] [Next] [Last]